Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models

2015244 citationsJournal Articlehybrid Open Access

Authors

Melissa A. Penny · University of Basel

Robert Verity · Imperial College London

Caitlin Bever · Bellevue Hospital Center

Christophe Sauboin · GlaxoSmithKline (Belgium)

Katya Galactionova · Swiss Tropical and Public Health Institute

Stefan Flasche · London School of Hygiene & Tropical Medicine

Michael White

Abstract

PATH Malaria Vaccine Initiative; Bill & Melinda Gates Foundation; Global Good Fund; Medical Research Council; UK Department for International Development; GAVI, the Vaccine Alliance; WHO.

Topics & Keywords

Malaria Research and Control Global Maternal and Child Health Parasites and Host Interactions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Lancet

Volume 387, Issue 10016, pp. 367-375

DOI: 10.1016/s0140-6736(15)00725-4

Field-Weighted Citation Impact: 20.85